Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

The effect of cratine on glycemic control in NIDDM poatients on sulfonylurea therapy (CROSBI ID 476707)

Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija

Ročić, Boris ; Znaor, Arijana ; Vučić, Marijana ; Profozić, Velimir ; Ročić, Petra ; Ashcroft, S.J.H. ; Metelko, Željko The effect of cratine on glycemic control in NIDDM poatients on sulfonylurea therapy // Diabetes. ADA, 1999. str. 1568-1569-x

Podaci o odgovornosti

Ročić, Boris ; Znaor, Arijana ; Vučić, Marijana ; Profozić, Velimir ; Ročić, Petra ; Ashcroft, S.J.H. ; Metelko, Željko

engleski

The effect of cratine on glycemic control in NIDDM poatients on sulfonylurea therapy

Creatine(N-methyl-N-guanylglycin) in known to play an important role in mechanochemical transduction processes generating ATP from phosphocreatine. Only few reports demonstrated its effect on regulation of glucose homeostasis.... The results demonstrated an identical insulinotropic potency uf sulfonylurea preparation (Euglucon N) and creatine, and the efficacy of glycemic control after oral administration of creatine is comparable to that obtained with Euglucon N. The efficacy of glycemic control is best achieved with the combination therapy (simultaneous application of Euglucon N and creatine ).

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

1568-1569-x.

1999.

objavljeno

Podaci o matičnoj publikaciji

Diabetes

ADA

Podaci o skupu

59th Anual Meeting of the American Diabetes Association

poster

19.06.1999-22.06.1999

San Diego (CA), Sjedinjene Američke Države

Povezanost rada

Kliničke medicinske znanosti